Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies. The only definitive therapy for end stage heart failure is orthotopic heart transplantation. Each year, it is estimated that more than 100,000 donor hearts are needed for cardiac transplantation procedures in the United States 